Sartorius Stedim Biotech S.A. (SDMHF)

200.90 0.00 (0.00%) At close: 04:00PM EDT

Sartorius Stedim Biotech S.A.

Zone Industrielle Les Paluds
Avenue de Jouques – CS 91051 Cedex
Aubagne 13781
France
33 4 42 84 56 00
https://www.sartorius.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 10,382

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Rene Faber	CEO & DIrector	603.56k	N/A	1975
Mr. Rainer Lehmann	CFO & Member of Executive Board	N/A	N/A	1975
Ms. Petra Muller	Head of Investor Relations	N/A	N/A	N/A
Ms. Petra Kirchhoff	Head of Corporate Communications & IR	N/A	N/A	1969
Olivier Guitard	Head of Controlling BPS	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

Corporate Governance

Sartorius Stedim Biotech S.A.’s ISS Governance QualityScore as of September 1, 2024 is 6. The pillar scores are Audit: 3; Board: 4; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.